These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 15529514)

  • 1. Durable efficacy of metformin/glibenclamide combination tablets (Glucovance) during 52 weeks of open-label treatment in type 2 diabetic patients with hyperglycaemia despite previous sulphonylurea monotherapy.
    Blonde L; Joyal S; Henry D; Howlett H
    Int J Clin Pract; 2004 Sep; 58(9):820-6. PubMed ID: 15529514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of initial hyperglycaemia, weight and age on the blood glucose lowering efficacy and incidence of hypoglycaemic symptoms with a single-tablet metformin-glibenclamide therapy (Glucovance) in type 2 diabetes.
    Garber A; Marre M; Blonde L; Allavoine T; Howlett H; Lehert P; Cornes M
    Diabetes Obes Metab; 2003 May; 5(3):171-9. PubMed ID: 12681024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerability profile of metformin/glibenclamide combination tablets (Glucovance): a new treatment for the management of type 2 diabetes mellitus.
    Davidson JA; Scheen AJ; Howlett HC
    Drug Saf; 2004; 27(15):1205-16. PubMed ID: 15588116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durability of efficacy and long-term safety profile of glyburide/metformin tablets in patients with type 2 diabetes mellitus: an open-label extension study.
    Garber AJ; Bruce S; Fiedorek FT
    Clin Ther; 2002 Sep; 24(9):1401-13. PubMed ID: 12380632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin-glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy.
    Garber A; Klein E; Bruce S; Sankoh S; Mohideen P
    Diabetes Obes Metab; 2006 Mar; 8(2):156-63. PubMed ID: 16448519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid effects of glyburide/metformin tablets in patients with type 2 diabetes mellitus with poor glycemic control and dyslipidemia in an open-label extension study.
    Dailey GE; Mohideen P; Fiedorek FT
    Clin Ther; 2002 Sep; 24(9):1426-38. PubMed ID: 12380634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved glycaemic control with metformin-glibenclamide combined tablet therapy (Glucovance) in Type 2 diabetic patients inadequately controlled on metformin.
    Marre M; Howlett H; Lehert P; Allavoine T
    Diabet Med; 2002 Aug; 19(8):673-80. PubMed ID: 12147149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-cell response to metformin-glibenclamide combination tablets (Glucovance) in patients with type 2 diabetes.
    Bruce S; Park JS; Fiedorek FT; Howlett HC
    Int J Clin Pract; 2006 Jul; 60(7):783-90. PubMed ID: 16846398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and pharmacodynamics of glyburide/metformin tablets (Glucovance) versus equivalent doses of glyburide and metformin in patients with type 2 diabetes.
    Donahue SR; Turner KC; Patel S
    Clin Pharmacokinet; 2002; 41(15):1301-9. PubMed ID: 12452739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
    Plosker GL; Figgitt DP
    Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter, randomized, double-masked, parallel-group assessment of simultaneous glipizide/metformin as second-line pharmacologic treatment for patients with type 2 diabetes mellitus that is inadequately controlled by a sulfonylurea.
    Goldstein BJ; Pans M; Rubin CJ
    Clin Ther; 2003 Mar; 25(3):890-903. PubMed ID: 12852706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic control with glyburide/metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: a randomized, double-blind trial.
    Dailey GE; Noor MA; Park JS; Bruce S; Fiedorek FT
    Am J Med; 2004 Feb; 116(4):223-9. PubMed ID: 14969649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glyburide/metformin tablets: a new therapeutic option for the management of Type 2 diabetes.
    Dailey GE
    Expert Opin Pharmacother; 2003 Aug; 4(8):1417-30. PubMed ID: 12877648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of glyburide-metformin combination tablet in patients with type 2 diabetes.
    Chien HH; Chang CT; Chu NF; Hsieh SH; Huang YY; Lee IT; Lee WJ; Tang YJ; Sheu WH
    J Chin Med Assoc; 2007 Nov; 70(11):473-80. PubMed ID: 18063500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acarbose versus glibenclamide on glycemic excursion and oxidative stress in type 2 diabetic patients inadequately controlled by metformin: a 24-week, randomized, open-label, parallel-group comparison.
    Wang JS; Lin SD; Lee WJ; Su SL; Lee IT; Tu ST; Tseng YH; Lin SY; Sheu WH
    Clin Ther; 2011 Dec; 33(12):1932-42. PubMed ID: 22078152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes.
    Garber AJ; Donovan DS; Dandona P; Bruce S; Park JS
    J Clin Endocrinol Metab; 2003 Aug; 88(8):3598-604. PubMed ID: 12915642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes.
    Katakami N; Yamasaki Y; Hayaishi-Okano R; Ohtoshi K; Kaneto H; Matsuhisa M; Kosugi K; Hori M
    Diabetologia; 2004 Nov; 47(11):1906-13. PubMed ID: 15565373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of type 2 diabetes: inadequate assessment of oral antidiabetic combinations.
    Prescrire Int; 2003 Feb; 12(63):28-30. PubMed ID: 12602406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Greater reductions in A1C in type 2 diabetic patients new to therapy with glyburide/metformin tablets as compared to glyburide co-administered with metformin.
    Blonde L; Wogen J; Kreilick C; Seymour AA
    Diabetes Obes Metab; 2003 Nov; 5(6):424-31. PubMed ID: 14617228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biphasic insulin aspart 30 plus metformin: an effective combination in type 2 diabetes.
    Kvapil M; Swatko A; Hilberg C; Shestakova M
    Diabetes Obes Metab; 2006 Jan; 8(1):39-48. PubMed ID: 16367881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.